Thyme Care closes Series C with CVS Health Ventures, a16z
Cancer care navigation company Thyme Care closed a $95 million Series C funding round.
Healthcare investment firm Concord Health Partners was the lead investor. Previous investors CVS Health Ventures, Andreessen Horowitz's Bio + Health fund, AlleyCorp, Foresite Capital, Echo Health Ventures and Frist Cressey Ventures joined in the $55 million equity raise. Banc of California will provide an additional $40 million in debt financing, according to a news release.
Related: Top digital health funding: Cedars-Sinai fund backs data startup
Thyme Care employs a care team comprising nurse practitioners, oncology nurses and resource specialists to coordinate support services, proactively manage symptoms and help members understand a cancer diagnosis.
The company said in the release it will use the funding to expand into new markets; invest in its existing oncology, primary care and health plan partnerships; and grow its clinical value-based care model.
The round brings Thyme Care’s total raised to $178 million, including the debt financing. The company received $60 million in an August 2023 Series B round followed by an undisclosed investment from CVS Health Ventures and Echo Health Ventures in May.
Huma raises $80M, reaches value near $1B
Huma Therapeutics, a startup that uses artificial intelligence to work with healthcare app developers, has raised $80 million in a round valuing the company at almost $1 billion. Read more.
Truvian gets $74M for blood testing platform
Truvian, a blood testing platform company, raised $74 million in an unlabeled round led by venture capital firms Wittington Ventures and GreatPoint Ventures.
Existing investors DNS Capital, Medical Excellence Capital, Tao Capital Partners, TYH Capital and 7wireVentures also participated.
Truvian looks to automate how patients undergo blood tests in clinics and pharmacies by providing lab results instantly through its platform. The company said in a release it has evaluated 50,000 blood samples across 5,000 donors. It will use the funds in part to get clearance from the U.S. Food and Drug Administration.
Freshpaint nabs $31M from Intel, Y Combinator
Data security startup Freshpaint closed a $30.7 million Series B financing round.
Venture capital firm Threshold led the round with participation from chipmaker Intel’s venture capital arm, startup accelerator Y Combinator and venture capital firms SignalFire and Zero Prime Ventures.
Freshpaint sells healthcare privacy products to companies with a focus on how they can market to patients without violating the Health Insurance Portability and Accountability Act of 1996. The startup said in a release it plans to use the funds to expand its offerings to hospitals, health insurance providers, pharmacies and retail healthcare companies.
The federal government has cracked down in the last year on how health systems use third-party tracking technology.
Khosla-backed Q Bio secures $27M
Q Bio, a full-body imaging company, received $27 million in an unlabeled funding round.
Telus Global Ventures, the venture arm of Vancouver, Canada-based wireless provider Telus, joined existing investors Khosla Ventures, Andreessen Horowitz, Founders Fund and Kaiser Foundation Hospitals in the round.
Q Bio has developed a magnetic resonance imaging device that uses artificial intelligence to give patients information on potential health risks. The company plans to use the funds to bring its full-body MRI scanner to market.
A growing number of startups are jostling for space in the full-body MRI market, including Ezra and Prenuvo.
Seven Starling gets $11M for women’s mental health
Seven Starling, a women’s mental health startup, netted $10.9 million in a Series A funding round.
Venture capital firm RH Capital led the round. Investors Pear VC, Expa, Magnify Ventures, Emerson Collective, Inflect Health, Zeal Capital Partners, Ulu Ventures, Fiore Ventures, Rogue Venture Partners, Graham and Walker and Wisdom Ventures also participated. The March of Dimes, a nonprofit focused on maternal health, also participated.
Seven Starling provides virtual behavioral care to women experiencing infertility, miscarriage, pregnancy, postpartum and other conditions. The company said in a release it works with more than 1,000 obstetricians and gynecologists at U.S. clinics and hospitals. It will use the funds to increase access to its services.
Redesign Health backs physical therapy startup Kins
Kins, a digital-first hybrid physical therapy practice, closed a $7 million Series A funding round.
Healthworx, the investment arm of CareFirst BlueCross BlueShield, participated in the round with startup creator Redesign Health. Venture capital firms W Health Ventures and Asahi Kasei Ventures also participated.
The company offers services to patients in New York and Massachusetts. The funding will allow it to expand into Washington, D.C., Maryland and Virginia, it said in a release.
